CN103519146A - Flammulina velutipes oral liquid - Google Patents
Flammulina velutipes oral liquid Download PDFInfo
- Publication number
- CN103519146A CN103519146A CN201310490534.2A CN201310490534A CN103519146A CN 103519146 A CN103519146 A CN 103519146A CN 201310490534 A CN201310490534 A CN 201310490534A CN 103519146 A CN103519146 A CN 103519146A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- oral liquid
- flammulina velutipes
- parts
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 15
- 240000006499 Flammulina velutipes Species 0.000 title abstract description 6
- 235000016640 Flammulina velutipes Nutrition 0.000 title abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 10
- 150000001413 amino acids Chemical class 0.000 claims abstract description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 5
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 5
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 5
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 5
- 229960000304 folic acid Drugs 0.000 claims abstract description 5
- 235000019152 folic acid Nutrition 0.000 claims abstract description 5
- 239000011724 folic acid Substances 0.000 claims abstract description 5
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims abstract description 5
- 239000011664 nicotinic acid Substances 0.000 claims abstract description 5
- 229960002477 riboflavin Drugs 0.000 claims abstract description 5
- 229960003495 thiamine Drugs 0.000 claims abstract description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 5
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 5
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 5
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 5
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 5
- 239000011718 vitamin C Substances 0.000 claims abstract description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 7
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 7
- 244000001632 Acorus gramineus Species 0.000 claims description 4
- 235000013073 Acorus gramineus Nutrition 0.000 claims description 4
- 240000006079 Schisandra chinensis Species 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 235000002020 sage Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 244000003416 Asparagus officinalis Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 4
- 229940088594 vitamin Drugs 0.000 abstract description 3
- 229930003231 vitamin Natural products 0.000 abstract description 3
- 235000013343 vitamin Nutrition 0.000 abstract description 3
- 239000011782 vitamin Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 210000005036 nerve Anatomy 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 241000234427 Asparagus Species 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to the technical field of medicine and health-care, and in particular relates to a flammulina velutipes oral liquid. Each 500mL of the liquid comprises the following components: 10,000mg of flammulina velutipes amino acid, 8,000mg of vitamin C, 3,000mg of vitamin B1, 4,500mg of vitamin B2, 200mg of folic acid, 1,000mg of calcium pantothenate, 2,000mg of nicotinic acid and 20,000mg of Chinese medicine extract. The flammulina velutipes oral liquid provided by the invention takes full advantage of the intelligence effect of the flammulina velutipes, and the human body resistance can be effectively improved, and the nutrition is supplied through compatibility with vitamins, amino acid and nerve calming and diuresis medicines.
Description
?
technical field
The present invention relates to medicines and health protection technical field, particularly a kind of golden mushroom oral liquid.
background technology
Ion Absorption of Flammulina Velutipes, containing nutritional labelings such as protein, amino acid and carbohydrate,, increases and plays an important role children's intelligence because being rich in arginine, lysine and several mineral materials and vitamin in Japan, is called as " intelligence development mushroom ".But about the deep processing of Asparagus, still there is the field of the exploration of much can going.
summary of the invention
In order to enrich Asparagus deep processed product, the invention provides a kind of golden mushroom oral liquid.
The present invention is achieved by the following measures:
, every 500mL liquid comprises following component:
Asparagus amino acid/11 0000mg, vitamin C 8000mg, vitamin B1 3000mg, vitamin B2 4500mg, folic acid 200mg, calcium pantothenate 1000mg, nicotinic acid 2000mg, Chinese medical extract 20000mg;
Described Chinese medical extract obtains by following steps:
By 120 parts of grass-leaved sweetflags, 80 parts, the fruit of Chinese magnoliavine, 80 parts of the reds sage root, take by weight, add the boiling water of 5-8 times of weight, boil 2-3 hour, filter to get filtrate, and being concentrated into relative density is 1.2, obtains.
Described golden mushroom oral liquid, also comprises 7mg sugar and 4mg citric acid.
Beneficial effect of the present invention: oral liquid of the present invention is given full play to Asparagus nootropic effect, with vitamin, amino acid, calm the nerves and diuretic compatibility, effectively strengthening body resistance, extra-nutrition.
The specific embodiment
For a better understanding of the present invention, below in conjunction with specific embodiment, further illustrate.
embodiment 1:
, every 500mL liquid comprises following component:
Asparagus amino acid/11 0000mg, vitamin C 8000mg, vitamin B1 3000mg, vitamin B2 4500mg, folic acid 200mg, calcium pantothenate 1000mg, nicotinic acid 2000mg, Chinese medical extract 20000mg;
Described Chinese medical extract obtains by following steps:
By 120 parts of grass-leaved sweetflags, 80 parts, the fruit of Chinese magnoliavine, 80 parts of the reds sage root, take by weight, add the boiling water of 5-8 times of weight, boil 2-3 hour, filter to get filtrate, and being concentrated into relative density is 1.2, obtains.
embodiment 2:
, every 500mL liquid comprises following component:
Asparagus amino acid/11 0000mg, vitamin C 8000mg, vitamin B1 3000mg, vitamin B2 4500mg, folic acid 200mg, calcium pantothenate 1000mg, nicotinic acid 2000mg, Chinese medical extract 20000mg, 7mg sugar and 4mg citric acid;
Described Chinese medical extract obtains by following steps:
By 120 parts of grass-leaved sweetflags, 80 parts, the fruit of Chinese magnoliavine, 80 parts of the reds sage root, take by weight, add the boiling water of 5-8 times of weight, boil 2-3 hour, filter to get filtrate, and being concentrated into relative density is 1.2, obtains.
Claims (2)
1. a golden mushroom oral liquid, is characterized in that every 500mL liquid comprises following component:
Asparagus amino acid/11 0000mg, vitamin C 8000mg, vitamin B1 3000mg, vitamin B2 4500mg, folic acid 200mg, calcium pantothenate 1000mg, nicotinic acid 2000mg, Chinese medical extract 20000mg;
Described Chinese medical extract obtains by following steps:
By 120 parts of grass-leaved sweetflags, 80 parts, the fruit of Chinese magnoliavine, 80 parts of the reds sage root, take by weight, add the boiling water of 5-8 times of weight, boil 2-3 hour, filter to get filtrate, and being concentrated into relative density is 1.2, obtains.
2. golden mushroom oral liquid according to claim 1, characterized by further comprising 7mg sugar and 4mg citric acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310490534.2A CN103519146A (en) | 2013-10-19 | 2013-10-19 | Flammulina velutipes oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310490534.2A CN103519146A (en) | 2013-10-19 | 2013-10-19 | Flammulina velutipes oral liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103519146A true CN103519146A (en) | 2014-01-22 |
Family
ID=49921783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310490534.2A Pending CN103519146A (en) | 2013-10-19 | 2013-10-19 | Flammulina velutipes oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103519146A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108497503A (en) * | 2017-06-15 | 2018-09-07 | 西南大学 | A kind of processing method of JINZHENGU protein anti-oxidation peptide oral solution |
-
2013
- 2013-10-19 CN CN201310490534.2A patent/CN103519146A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108497503A (en) * | 2017-06-15 | 2018-09-07 | 西南大学 | A kind of processing method of JINZHENGU protein anti-oxidation peptide oral solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101040705B (en) | Functional health-care edible seepweed plant salt and the method for preparing the same | |
| CN102415568B (en) | Health food for improving immunity and preparation method thereof | |
| CN101756090B (en) | Physical power recovery agent and applications thereof | |
| CN101238886A (en) | Salidroside fatigue-resistance beverage | |
| CN102845795A (en) | Functional health-care beverage | |
| CN104939099A (en) | Additive-free compound protein powder used for human body anti-fatigue function | |
| CN103283847A (en) | Multi-nutritional protein | |
| CN104783185B (en) | It is a kind of that there is strengthen immunity, health food of function of physical fatigue alleviation and preparation method thereof | |
| CN103284093B (en) | Six-ingredient lepidium meyenii walp health-care pill and preparation method thereof | |
| CN101185706B (en) | Hippophae rhamnoides nutrition mixture with delaying senility function and preparation technique thereof | |
| CN103519146A (en) | Flammulina velutipes oral liquid | |
| CN101766316A (en) | Coconut peptide water beverage, preparation method and purpose thereof | |
| CN102224893B (en) | Health oral liquid | |
| CN106418536A (en) | Selenium-enriched extract and manufacture method thereof | |
| CN105595129A (en) | Sea-buckthorn composite concentrated solution capable of promoting growth of children and protecting eyesight and preparation method thereof | |
| CN106031491A (en) | Hericium erinaceus-hawthorn beverage | |
| CN103719488A (en) | Eyesight-improving refreshing fruit tea and preparation method thereof | |
| CN103355581A (en) | Lucid ganoderma healthy nutritional oral liquid and preparation method | |
| CN103621636A (en) | Flammulina velutipes intelligence-promoting beverage | |
| CN101595985A (en) | A kind of Worm grass mushrooms essence oral liquid | |
| CN105999135A (en) | Salted ginger tea for Dragon Boat Festival | |
| CN104223242A (en) | Movement functional Chinese medicinal herb beverage | |
| CN104872602A (en) | Health preserving composition using hericium erinaceus as main raw materials | |
| CN106798074A (en) | A kind of deep-sea fish oligopeptide albumen powder with enhance immunity function | |
| CN100566598C (en) | A kind of contain bamboo embryo powder improve health products of anaemia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140122 |
|
| WD01 | Invention patent application deemed withdrawn after publication |